Skip to search.
 FTSE 100 Down 0.74%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
10.06 Down 0.22(2.14%) 3 Mar 21:00
|After Hours: : 10.06 0.00 (0.00%) 21:50
Add to Portfolio
Prev Close:10.28
Open:10.22
Bid:9.92 x 400
Ask:N/A
1y Target Est:17.11
Beta:4.08
Next Earnings Date: 7-May-15BCRX Earnings announcement
Day's Range:10.03 - 10.26
52wk Range:7.29 - 14.62
Volume:572,121
Avg Vol (3m):881,547
Market Cap:722.94m
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXDown 2.14%722.94m
GSKDown 0.46%114.77b
RHHBYUp 1.07%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):54.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.07
Quarterly EPS Est (Mar-15) :-0.25
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):0.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback